Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
176 JPY | -1.12% | -8.81% | -7.37% |
2023 | NANO MRNA, Kao Tie Up to Develop mRNA Therapies for Allergic Diseases | MT |
2023 | NANO MRNA Co., Ltd. and Kao Corporation Agree a Comprehensive Collaborative Research for mRNA Drug Discovery | CI |
Sales * | - | Sales 1 * | - | Capitalization | 16.83B 109M |
---|---|---|---|---|---|
Net income * | - | Net income 1 * | - | EV / Sales * | - |
Net cash position * | - 0 | Net cash position 1 * | - 0 | EV / Sales 1 * | - |
P/E ratio * |
-
| P/E ratio 1 * |
-
| Employees | 17 |
Yield * |
-
| Yield 1 * |
-
| Free-Float | 93.47% |
1 day | -1.12% | ||
1 week | -8.81% | ||
Current month | -4.86% | ||
1 month | +1.15% | ||
3 months | -6.38% | ||
6 months | +1.73% | ||
Current year | -7.37% |
Managers | Title | Age | Since |
---|---|---|---|
Shiro Akinaga
CEO | Chief Executive Officer | 67 | 20-05-31 |
Koji Fujimoto
DFI | Director of Finance/CFO | 51 | 02-10-31 |
Comptroller/Controller/Auditor | 61 | 14-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Satoru Iino
BRD | Director/Board Member | 58 | 12-02-29 |
Kazunori Kataoka
FOU | Founder | 73 | 96-06-13 |
Teruo Okano
FOU | Founder | 75 | 96-06-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 176 | -1.12% | 316,300 |
24-04-16 | 178 | -3.78% | 545,100 |
24-04-15 | 185 | +2.78% | 397,600 |
24-04-12 | 180 | -2.70% | 371,700 |
24-04-11 | 185 | -1.60% | 447,000 |
Delayed Quote Japan Exchange, April 17, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-7.37% | 81.08M | |
-3.39% | 102B | |
+2.61% | 96.09B | |
-1.02% | 22.05B | |
-18.14% | 20.81B | |
-6.87% | 19.06B | |
-40.70% | 16.05B | |
-26.89% | 14.01B | |
+1.12% | 13.38B | |
+22.25% | 11.01B |
- Stock Market
- Equities
- 4571 Stock